Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Taneja

Showing results (281-290 of 845) with videos related to

Pageof 85
Sort By:
The Urologic Clinics of North America|April 2, 2013
Urologic Clinics of North America. Diagnosis, evaluation, and treatment of non-muscle invasive bladder cancer. ForewordSamir S Taneja
The Journal of Urology|April 13, 2012
Re: inadequacy of biopsy for diagnosis of upper tract urothelial carcinoma: implications for conservative managementSamir S Taneja
The Journal of Urology|October 4, 2014
Re: metformin use and all-cause and prostate cancer-specific mortality among men with diabetesSamir S Taneja
The Journal of Urology|October 4, 2014
Re: marital status and survival in patients with cancerSamir S Taneja
The Journal of Urology|November 12, 2013
Re: Germline BRCA mutations are associated with higher risk of nodal involvement, distant metastasis, and poor survival outcomes in prostate cancerSamir S Taneja
The Journal of Urology|November 12, 2013
Re: Androgen-deprivation therapy alone or with docetaxel in non-castrate metastatic prostate cancer (GETUG-AFU 15): a randomised, open-label, phase 3 trialSamir S Taneja
The Journal of Urology|December 17, 2016
Re: Efficacy and Safety of Enzalutamide versus Bicalutamide for Patients with Metastatic Prostate Cancer (TERRAIN): A Randomised, Double-Blind, Phase 2 StudySamir S Taneja
The Journal of Urology|April 8, 2014
Re: Androgen deprivation therapy and risk of acute kidney injury in patients with prostate cancerSamir S Taneja
The Journal of Urology|April 22, 2014
Re: prostate cancer imaging trends after a nationwide effort to discourage inappropriate prostate cancer imagingSamir S Taneja
The Journal of Urology|October 19, 2016
Re: Redirecting Abiraterone Metabolism to Fine-Tune Prostate Cancer Anti-Androgen TherapySamir S Taneja
Pageof 85

Showing results (281-290 of 845) with videos related to

Sort By:
Pageof 85
The Urologic Clinics of North America|April 2, 2013
Urologic Clinics of North America. Diagnosis, evaluation, and treatment of non-muscle invasive bladder cancer. ForewordSamir S Taneja
The Journal of Urology|April 13, 2012
Re: inadequacy of biopsy for diagnosis of upper tract urothelial carcinoma: implications for conservative managementSamir S Taneja
The Journal of Urology|October 4, 2014
Re: metformin use and all-cause and prostate cancer-specific mortality among men with diabetesSamir S Taneja
The Journal of Urology|October 4, 2014
Re: marital status and survival in patients with cancerSamir S Taneja
The Journal of Urology|November 12, 2013
Re: Germline BRCA mutations are associated with higher risk of nodal involvement, distant metastasis, and poor survival outcomes in prostate cancerSamir S Taneja
The Journal of Urology|November 12, 2013
Re: Androgen-deprivation therapy alone or with docetaxel in non-castrate metastatic prostate cancer (GETUG-AFU 15): a randomised, open-label, phase 3 trialSamir S Taneja
The Journal of Urology|December 17, 2016
Re: Efficacy and Safety of Enzalutamide versus Bicalutamide for Patients with Metastatic Prostate Cancer (TERRAIN): A Randomised, Double-Blind, Phase 2 StudySamir S Taneja
The Journal of Urology|April 8, 2014
Re: Androgen deprivation therapy and risk of acute kidney injury in patients with prostate cancerSamir S Taneja
The Journal of Urology|April 22, 2014
Re: prostate cancer imaging trends after a nationwide effort to discourage inappropriate prostate cancer imagingSamir S Taneja
The Journal of Urology|October 19, 2016
Re: Redirecting Abiraterone Metabolism to Fine-Tune Prostate Cancer Anti-Androgen TherapySamir S Taneja
Pageof 85